Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Antioxidants 9(8):123
Results showed that GLP-1 receptor agonists and SGLT2 inhibitors were superior in reducing the risk of MACE when compared to DPP-4 inhibitors (HR 086 [082089] and 086 [082090], respectively), but no difference was found between SGLT2 inhibitors and GLP-1 receptor agonists in reducing rate of MACE (HR of 101 (094107)) (68)
To view a copy of this licence, visit About this article Cite this article He, W., Wei, J., Liu, X
Zahrawi F et al
US$ 20.35
US$ 27.17
US$ 28.09
